These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9179372)

  • 1. Mistletoe therapy and immunological research.
    Büssing A
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S65. PubMed ID: 9179372
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mistletoe therapy. An alternative cancer treatment].
    Ernst E
    MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of mistletoe therapy in carcinoma patients].
    Rostock M; Unger C
    Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy.
    Stein G; Henn W; von Laue H; Berg P
    Eur J Med Res; 1998 Apr; 3(4):194-202. PubMed ID: 9533928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non hodgkin lymphoma].
    Pierach CA
    Dtsch Med Wochenschr; 2000 Aug; 125(31-32):958-60. PubMed ID: 10967963
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of a mistletoe preparation on suspension cell cultures of human leukemia and human myeloma cells.
    Hülsen H; Mechelke F
    Arzneimittelforschung; 1982; 32(9):1126-7. PubMed ID: 6890837
    [No Abstract]   [Full Text] [Related]  

  • 7. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
    Mengs U; Göthel D; Leng-Peschlow E
    Anticancer Res; 2002; 22(3):1399-407. PubMed ID: 12168816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice.
    Mengs U; Schwarz T; Bulitta M; Weber K
    Anticancer Res; 2000; 20(5B):3565-8. PubMed ID: 11131663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytostatic activity of Viscum cruciatum Sieber on cellular cultures. Acute toxicity].
    Ayuso MJ; de Miguel C; Saenz MT
    Ann Pharm Fr; 1985; 43(5):459-61. PubMed ID: 3835836
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
    Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
    Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An allergy to mistletoe extract].
    Pichler WJ; Angeli R
    Dtsch Med Wochenschr; 1991 Aug; 116(35):1333-4. PubMed ID: 1879330
    [No Abstract]   [Full Text] [Related]  

  • 12. Mistletoe: a story with an open end.
    Büssing A
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S1-2. PubMed ID: 9179358
    [No Abstract]   [Full Text] [Related]  

  • 13. Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts.
    Knöpfl-Sidler F; Viviani A; Rist L; Hensel A
    Pharmazie; 2005 Jun; 60(6):448-54. PubMed ID: 15997835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
    Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
    BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personal experiences in naturopathy. Mistletoe in therapy].
    Zimmermann W
    Fortschr Med; 1987 Jun; 105(17):13, 16. PubMed ID: 3609997
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extracts of mistletoe in cancer therapy].
    Jensen K
    Ugeskr Laeger; 1982 Mar; 144(13):961-3. PubMed ID: 7101540
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract.
    Stein GM; Berg PA
    Eur J Med Res; 1999 May; 4(5):169-77. PubMed ID: 10336405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oncologic mistletoe therapy--physicians' use and estimation of efficiency].
    Stein GM
    Dtsch Med Wochenschr; 2001 Jul; 126(28-29):833-4. PubMed ID: 11499270
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mistletoe therapy--physicians warned. No acceptable ground for cancer diagnosis].
    Lakartidningen; 1975 Apr; 72(18):1931-2. PubMed ID: 1128097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.